Upgrade to SI Premium - Free Trial

Enanta Pharma (ENTA)

17.46 +0.93 (5.63%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/6/24)

Latest Headlines

Form 8-K ENANTA PHARMACEUTICALS For: Mar 06 March 12, 2024 4:00 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 06 Filed by: Vance Terry March 8, 2024 5:30 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 06 Filed by: Russell Lesley March 8, 2024 5:28 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 06 Filed by: Peterson Kristine March 8, 2024 5:24 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 06 Filed by: Hata Yujiro S March 8, 2024 5:19 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 06 Filed by: FOLETTA MARK G March 8, 2024 5:16 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Mar 06 Filed by: CARTER BRUCE L A March 8, 2024 5:13 PM - SEC Filing Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference March 6, 2024 7:00 AM - BizWire Form 4 ENANTA PHARMACEUTICALS For: Feb 26 Filed by: Gardiner Nathaniel S. February 27, 2024 6:32 PM - SEC Filing Form SCHEDULE 13G ENANTA PHARMACEUTICALS Filed by: Krensavage Asset Management, LLC February 27, 2024 1:12 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Luu Brendan February 14, 2024 8:24 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Kieffer Tara Lynn February 14, 2024 8:22 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Gardiner Nathaniel S. February 14, 2024 8:19 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Rottinghaus Scott T. February 14, 2024 8:16 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Or Yat Sun February 14, 2024 8:13 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: MELLETT PAUL J February 14, 2024 8:10 PM - SEC Filing Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Luly Jay R. February 14, 2024 8:01 PM - SEC Filing Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC February 14, 2024 2:27 PM - SEC Filing Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: VANGUARD GROUP INC February 13, 2024 5:06 PM - SEC Filing Enanta Pharmaceuticals (ENTA) PT Lowered to $17 at Oppenheimer February 9, 2024 7:36 AM - StreetInsider Form EFFECT ENANTA PHARMACEUTICALS February 9, 2024 6:03 AM - SEC Filing Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31 February 8, 2024 4:25 PM - SEC Filing Enanta Pharmaceuticals (ENTA) PT Lowered to $11 at JPMorgan February 8, 2024 7:26 AM - StreetInsider Enanta Pharmaceuticals (ENTA) PT Lowered to $26 at Baird February 8, 2024 6:29 AM - StreetInsider Form 8-K ENANTA PHARMACEUTICALS For: Feb 07 February 7, 2024 4:06 PM - SEC Filing Enanta Pharma (ENTA) Misses Q1 EPS by 175c February 7, 2024 4:03 PM - StreetInsider Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET February 7, 2024 4:01 PM - BizWire Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 6, 2024 7:00 AM - BizWire Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023 January 31, 2024 7:00 AM - BizWire Form ARS ENANTA PHARMACEUTICALS For: Sep 30 January 26, 2024 4:40 PM - SEC Filing Form DEFA14A ENANTA PHARMACEUTICALS January 26, 2024 4:38 PM - SEC Filing Form DEF 14A ENANTA PHARMACEUTICALS For: Mar 06 January 26, 2024 4:27 PM - SEC Filing Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: Farallon Capital Partners, L.P. January 26, 2024 9:12 AM - SEC Filing Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: BlackRock Inc. January 24, 2024 5:25 PM - SEC Filing Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: STATE STREET CORP January 22, 2024 12:25 PM - SEC Filing Enanta Pharma (ENTA): Millennium Management Reports 6.2% Passive Stake January 11, 2024 4:23 PM - StreetInsider Form SC 13G ENANTA PHARMACEUTICALS Filed by: MILLENNIUM MANAGEMENT LLC January 11, 2024 4:16 PM - SEC Filing Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference January 4, 2024 7:00 AM - BizWire Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 3, 2024 7:00 AM - BizWire Full Article List